SOLESENCE Business Summary

Solésence, Inc. (SLSN) operates as a specialized life sciences and beauty technology company, primarily generating revenue through the development and contract manufacturing of mineral-based skin health products. The company’s business model is bifurcated into high-growth Consumer Products—which accounts for over 95% of total revenue—and a legacy segment providing Personal Care Ingredients and Advanced Materials. Solésence leverages its proprietary, award-winning mineral UV protection technology to provide end-to-end formulation and production services for prestige beauty brands, while also scaling its own internal brands such as Stress Defense, Kleair, and Bloom. In the competitive landscape, Solésence contends with contract manufacturers like Voyant Beauty and ingredient specialists such as United-Guardian, as well as vertically integrated players like e.l.f. Beauty. The company distinguishes itself as a premium innovator in the "clean beauty" sector, specifically targeting the intersection of dermatological health and aesthetic wearability. Following a strategic rebranding from Nanophase Technologies in early 2025 and a subsequent uplisting to the Nasdaq, the company is led by President and CEO Kevin Cureton, who previously served as COO and brought over 20 years of chemical and personal care experience from AMCOL International and Air Products. The executive team was further bolstered in late 2025 and early 2026 with the appointments of CFO Laura Riffner, a 35-year finance veteran from Nagase America, and Yoolie Park as VP of Brand Partnerships, formerly of Paklab. Technical innovation remains under the guidance of Chief Scientific Officer Dr. Harry Sarkas, an expert in photophysics with over 25 years of experience in material synthesis. The company is overseen by a board chaired by Janet Whitmore and maintains significant institutional backing from major firms including JPMorgan Chase and Bank of America, reflecting its transition from a materials supplier to a leading skin health CDMO.